Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Mount Sinai Medical Center, New York

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

Johns Hopkins Medicine, Baltimore

Duke Neurology, Durham

Baptist Health, Nemours Children's Specialty Care, Jacksonville

The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham, Birmingham

University of Kentucky, Lexington

University Hospitals Cleveland Medical Center, Cleveland

Cleveland Clinic, Cleveland

The Regents of The University of Michigan, Ann Arbor

Michigan State University, East Lansing

Minneapolis Clinic of Neurology, Golden Valley

RUSH University Medical Center, Chicago

Arkansas Epilepsy Program, Little Rock

UT Southwestern Medical Center, Dallas

Children's Hospital of San Antonio, San Antonio

Barrow Neurological Institute, Phoenix

UNM Health Providers, Albuquerque

UCSD Epilepsy Center, La Jolla

Stanford Medical Center, Palo Alto

UC Davis Medical Center, Sacramento

Tufts Medical Center, Boston

JFK Medical Center, Edison

Northeast Regional Epilepsy Group, Hackensack